(Q38011313)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607896%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Meningococcal disease: clinical presentation and sequelae (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607896%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

main subject

meningococcal disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607896%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

2

Andrew J Pollard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607896%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

1 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607896%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607896%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

30 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607896%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

B3-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607896%20AND%20SRC:MED&resulttype=core&format=json

Manson Lecture. Meningococcal meningitis in Africa.

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

A surveillance network for meningococcal disease in Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Bacterial meningitis--a view of the past 90 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Editorial: 100 years of epidemic meningitis in West Africa - has anything changed?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

SERUM TREATMENT OF EPIDEMIC CEREBRO-SPINAL MENINGITIS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

IN VIVO AND IN VITRO RESISTANCE TO SULFADIAZINE IN STRAINS OF NEISSERIA MENINGITIDIS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Meningococcal carriage in the African meningitis belt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Genetic Analysis of Meningococci Carried by Children and Young Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

The Effect of Chemoprophylactic Use of Rifampin and Minocycline on Rates of Carriage of Neisseria meningitidis in Army Recruits in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Social behavior and meningococcal carriage in British teenagers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Tobacco use increases susceptibility to bacterial infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Environmental exposures and invasive meningococcal disease: an evaluation of effects on varying time scales.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Environmental risk and meningitis epidemics in Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Disco fever: epidemic meningococcal disease in northeastern Argentina associated with disco patronage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Postsplenectomy sepsis and its mortality rate: actual versus perceived risks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Immunological Investigations of Meningococcal Disease: III. Brevity of Group C Acquisition Prior to Disease Occurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

SPREAD OF MENINGOCOCCAL INFECTION WITHIN HOUSEHOLDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Severity of meningococcal disease associated with genomic bacterial load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Genetic polymorphisms in host response to meningococcal infection: the role of susceptibility and severity genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Clinical recognition of meningococcal disease in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Interaction mechanisms of encapsulated meningococci with eucaryotic cells: what does this tell us about the crossing of the blood-brain barrier by Neisseria meningitidis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Clinical features, laboratory findings and management of meningococcal meningitis in England and Wales: report of a 1997 survey. Meningococcal meningitis: 1997 survey report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Community-acquired purulent meningitis: a review of 1,316 cases during the antibiotic era, 1954-1976.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Acute bacterial meningitis in children presenting to the Royal Liverpool Children's Hospital, Liverpool, UK and the Queen Elizabeth Central Hospital in Blantyre, Malawi: a world of difference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Childhood bacterial meningitis: initial symptoms and signs related to age, and reasons for consulting a physician

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Bacterial meningitis in the first three months of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Bacterial meningitis in childhood at the Children's Hospital of Pittsburgh: 1988-1998

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Features and outcome in meningococcal disease presenting with maculopapular rash

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Pathophysiology of meningococcal meningitis and septicaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Risk factors for development of bacterial meningitis among children with occult bacteremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Incidence of bacteremia in infants and children with fever and petechiae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

The child with a non-blanching rash: how likely is meningococcal disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

The management of fever and petechiae: making sense of rash decisions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Meningococcal pneumonia: characterization and review of cases seen over the past 25 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Primary meningococcal pericarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Primary meningococcal conjunctivitis: report of 21 patients and review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

CHRONIC MENINGOCOCCEMIA. CASE REPORT AND REVIEW OF THE LITERATURE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Association of chronic meningococcemia with infection by meningococci with underacylated lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Chronic meningococcaemia: a forgotten meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Complement and immunoglobulin studies in 15 cases of chronic meningococcemia: properdin deficiency and hypoimmunoglobulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Chronic meningococcemia in a child with a deficiency of the sixth component of complement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Allergic complications of meningococcal disease. II. Immunological investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Allertic complications of meningococcal disease. I. Clinical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Immune complex associated complications in the subacute phase of meningococcal disease: incidence and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Clinical features and outcome of pediatric Neisseria meningitidis serogroup W135 infection: a report of 5 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Complications and sequelae of meningococcalinfections in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Neurodevelopmental outcome in meningococcal disease: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Multicenter surveillance of invasive meningococcal infections in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Long-term health status in childhood survivors of meningococcal septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Sequelae due to bacterial meningitis among African children: a systematic literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Long-term skin scarring and orthopaedic sequelae in survivors of meningococcal septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Late orthopaedic sequelae following meningococcal septicaemia. A multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Long-term outcome of meningococcal sepsis-associated acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Five-year outcomes of severe acute kidney injury requiring renal replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Parents' experiences of living through their child's suffering from and surviving severe meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Short-term psychiatric adjustment of children and their parents following meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Longer-term psychiatric adjustment of children and parents after meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Parents' perceived vulnerability and perceived control in preventing Meningococcal C infection: a large-scale interview study about vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

Hospital costs, length of stay and mortality associated with childhood, adolescent and young adult meningococcal disease in the US.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

An analysis of successful litigation claims in children in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

7 January 2021

Meningococcal sequelae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.062

10.1016/J.VACCINE.2011.12.062

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607896%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference